IL-33 Depletion in COVID-19 Lungs

Autor:	Stanley J. Radio, Heather M. Strah, Kristina L. Bailey, Michael J. Duryee, John D. Dickinson, Ted R. Mikuls, Bryant R. England, Todd A. Wyatt, Amy Nelson, Jill A. Poole, Dawn M. Katafiasz, Daniel R. Anderson, Rohit Gaurav, Geoffrey M. Thiele, Debra J. Romberger
Rok vydání:	2021
Předmět:	Adult Male Pulmonary and Respiratory Medicine 2019-20 coronavirus outbreak Coronavirus disease 2019 (COVID-19) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Myocytes Smooth Muscle Critical Care and Intensive Care Medicine SARS-CoV-2 severe acute respiratory syndrome coronavirus 2 lung Pulmonary Disease Chronic Obstructive Young Adult IL-33 Interleukin-33 proSP-C prosurfactant protein C Research Letter Humans Vimentin IPF idiopathic pulmonary fibrosis Medicine Aged Aged 80 and over SARS-CoV-2 business.industry COVID-19 Endothelial Cells Fibroblasts Middle Aged AEC2 type II alveolar epithelial cells Interleukin-33 Pulmonary Surfactant-Associated Protein C Virology Idiopathic Pulmonary Fibrosis Interleukin 33 COPD chronic obstructive pulmonary disease inflammation Alveolar Epithelial Cells Case-Control Studies SARS-CoV2 IL-33 Female Cardiology and Cardiovascular Medicine business
Zdroj:	Chest
ISSN:	0012-3692
DOI:	10.1016/j.chest.2021.06.058
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80ff0bce2e66fbc5668733449b28b9d6 https://doi.org/10.1016/j.chest.2021.06.058 Zobrazit plný text záznamu